https://orcid.org/0000-0002-0416-5115
References
- Landgren O, Shim YK, Michalek J, et al. Agent Orange exposure and monoclonal gammopathy of undetermined significance: an Operation Ranch Hand Veteran Cohort Study. JAMA Oncol. 2015;1(8):1061–1068. doi:10.1001/jamaoncol.2015.2938
- Dodlapati J, Hall JA, Kulkarni P, et al. Agent Orange exposure, transformation from MGUS to multiple myeloma, and outcomes in veterans. Fed Pract. 2022;39(Suppl. 3):S23–S29a.
- Bumma N, Nagasaka M, Hemingway G, et al. Effect of exposure to Agent Orange on the risk of monoclonal gammopathy and subsequent transformation to multiple myeloma: a single-center experience from the Veterans Affairs Hospital, Detroit. Clin Lymphoma Myeloma Leuk. 2020;20(5):305–311. doi:10.1016/j.clml.2019.11.014
- Fillmore NR, Yellapragada SV, Ifeorah C, et al. With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study. Blood. 2019;133(24):2615–2618. doi:10.1182/blood.2019000406
- VA Informatics and Computing Infrastructure (VINCI), VA ORD 22-D4V, U.S. Department of Veterans Affairs; 2008 [cited 2022 Aug 1]. Available from: https://vincicentral.vinci.med.va.gov
- Veterans Health Administration Center of Excellence for Suicide Prevention. Joint Department of Veterans Affairs and Department of Defense Mortality Data Repository. Data compiled from the National Death Index; 2022 [cited 2022 Dec 6]. Available from: https://www.mirecc.va.gov/suicideprevention/documents/VA_DoD-MDR_Flyer.pdf